Regenerative Med Continues Growth

regenerative-medicine-marketThe robust run-up of regenerative medicine procedures is projected to continue its acceleration over the next 10 years, according to industry forecasts.

This $22B global industry, which includes gene therapies, tissue engineering, and cell therapies amongst other procedures, is expected to approach $175B by 2032.

The US remains the largest geographical segment of this market, with North America accounting for nearly half of the market’s volume.

The global regenerative medicine market size was accounted for USD 22.24 billion in 2022 and it is predicted to be worth around USD 174.72 billion by 2032 with a remarkable CAGR of 22.8% from 2023 to 2032. U.S. regenerative medicine market was valued at USD 11.13 billion in 2022.

Read more at Precedence Research: Regenerative Medicine Market Size To Attain USD 174.72 Bn By 2032

Leave a Reply

Your email address will not be published. Required fields are marked *